Prof. Dr. Madeleine Durbeej leads the Muscle Biology unit at Lund University, Sweden, which researches laminin ɑ2 chain-deficient congenital muscular dystrophy. Over the years, they have been able to identify the affected genes and proteins of the disease using various approaches. Based on this information, the unit has explored different genetic and pharmacological interventions to improve the well-being of the patients.